alpha-hel-CRF (9-41)-based long-acting astressins (Sentia)

N/A

Report date: 2025/01/26 18:34:49

Base Information

Drug Namealpha-hel-CRF (9-41)-based long-acting astressins (Sentia)
Drug Alias NameCRF1/2 antagonizing astressins (Sentia)CRF1/2 antagonizing astressins (Salk Institute)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCorticotropin-releasing factor receptor 2 antagonistsCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1Corticotropin-releasing factor receptor 2
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSalk Institute for Biological Studies
China Registration ClassN/A

Develop Information

Active CompaniesSentia Medical Sciences Inc
Inactive CompaniesN/A
Active IndicationsIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A